Skip to main content
Clinical Trials/ACTRN12620001241921
ACTRN12620001241921
Recruiting
未知

To investigate transcutaneous spinal cord stimulation combined with locomotor training on walking ability in people with chronic spinal cord injury: a multi-centre double-blinded randomised sham-controlled trial

euroscience Research Australia0 sites50 target enrollmentNovember 20, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
spinal cord injury
Sponsor
euroscience Research Australia
Enrollment
50
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2020
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
euroscience Research Australia

Eligibility Criteria

Inclusion Criteria

  • A person will be eligible to participate if they:
  • have a SCI sustained a minimum of 12 months prior to consent
  • have bilateral motor levels between T1 and T11
  • have a Walking Index for Spinal Cord Injury II (WISCI II) between Level 1 and 6\*
  • have a reproducible, voluntary muscle flicker/contraction in at least one muscle that flexes or extends the hip, knee, ankle or big toe, on either side of the body
  • are willing and able to participate in the stimulation/locomotor training program 3 times a week for 12 weeks, including one follow\-up visit at 16 weeks
  • are aged 16 years or over at the time of consent and able to give informed consent
  • are considered by their spinal specialist to be medically stable to undertake the program (including clearance for standing/locomotor training)
  • \*1 \= Ambulates in parallel bars, with braces and physical assistance of two persons, but less than 10 metres
  • 6 \= Ambulates with walker, with braces and physical assistance of one person, 10 metres

Exclusion Criteria

  • A person will be ineligible to participate if they:
  • have a history of clinically significant autonomic dysreflexia in response to electrical stimulation
  • cannot tolerate transcutaneous spinal stimulation at a therapeutic intensity
  • have a history of hypotension in response to prolonged standing
  • have a progressive neurological disease and any other major neurological lesion additional to the spinal cord injury, e.g., a severe traumatic brain injury or stroke
  • have a history of long\-bone fracture, family history of fragility fracture or any disorders of the bone, such as Paget’s disease
  • have a syringomyelia (syrinx) on recent MRI. Radiological findings such as myelomalacia which have been evaluated by a neurosurgeon as non\-progressive may still be eligible
  • have had open surgery within the last 3 months
  • unable to elicit reflexes whilst experiencing the stimulation suggesting a lower motor neurone lesion
  • have severe lower limb spasticity (MAS \= 4 in any lower limb muscle)

Outcomes

Primary Outcomes

Not specified

Similar Trials